Insmed (INSM) Amortization of Deferred Charges (2012 - 2026)

Insmed's Amortization of Deferred Charges history runs 15 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges fell 24.15% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $84000.0, a 98.77% decrease from a year earlier, with the FY2025 full-year figure at $524000.0, down 92.39% from the prior year.
• Amortization of Deferred Charges advanced to $1.4 million in Q1 2026 per INSM's latest filing, from -$4.3 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $2.0 million in Q2 2023 and bottomed at -$4.3 million in Q4 2025.
• The 5-year median for Amortization of Deferred Charges is $1.7 million (2025), against an average of $1.2 million.
• Across the five-year window, Amortization of Deferred Charges surged 144.09% in 2023 and tumbled 346.91% in 2025, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $1.5 million in 2022, then rose by 14.81% to $1.8 million in 2023, then retreated by 0.23% to $1.7 million in 2024, then tumbled by 346.91% to -$4.3 million in 2025, then soared by 132.02% to $1.4 million in 2026.
• Per Business Quant, the three latest INSM Amortization of Deferred Charges figures stand at $1.4 million (Q1 2026), -$4.3 million (Q4 2025), and $1.3 million (Q3 2025).